Cellebrite DI Statistics
Share Statistics
Cellebrite DI has 239.47M
shares outstanding. The number of shares has increased by 16.65%
in one year.
| Shares Outstanding | 239.47M |
| Shares Change (YoY) | 16.65% |
| Shares Change (QoQ) | 15.08% |
| Owned by Institutions (%) | 52.49% |
| Shares Floating | n/a |
| Failed to Deliver (FTD) Shares | 302 |
| FTD / Avg. Volume | 0.02% |
Short Selling Information
The latest short interest is 988.16K, so 0.41% of the outstanding
shares have been sold short.
| Short Interest | 988.16K |
| Short % of Shares Out | 0.41% |
| Short % of Float | 0.85% |
| Short Ratio (days to cover) | 1.35 |
Valuation Ratios
The PE ratio is -16.31 and the forward
PE ratio is 55.17.
Cellebrite DI's PEG ratio is
-0.08.
| PE Ratio | -16.31 |
| Forward PE | 55.17 |
| PS Ratio | 11.5 |
| Forward PS | 6.7 |
| PB Ratio | 13.73 |
| P/FCF Ratio | 37.96 |
| PEG Ratio | -0.08 |
Financial Ratio HistoryEnterprise Valuation
Currently the Enterprise Value (EV) is not available for Cellebrite DI.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.92,
with a Debt / Equity ratio of 0.03.
| Current Ratio | 1.92 |
| Quick Ratio | 1.89 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | 0.09 |
| Interest Coverage | 0.16 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $343,790.06 |
| Profits Per Employee | $-242,508.14 |
| Employee Count | 1,167 |
| Asset Turnover | 0.58 |
| Inventory Turnover | 7 |
Taxes
| Income Tax | 7.02M |
| Effective Tax Rate | -2.54% |
Stock Price Statistics
The stock price has increased by 78.05% in the
last 52 weeks. The beta is 1.44, so Cellebrite DI's
price volatility has been higher than the market average.
| Beta | 1.44 |
| 52-Week Price Change | 78.05% |
| 50-Day Moving Average | 18.97 |
| 200-Day Moving Average | 18.99 |
| Relative Strength Index (RSI) | 57.65 |
| Average Volume (20 Days) | 1,532,732 |
Income Statement
In the last 12 months, Cellebrite DI had revenue of 401.2M
and earned -283.01M
in profits. Earnings per share was -1.35.
| Revenue | 401.2M |
| Gross Profit | 338.61M |
| Operating Income | 56.91M |
| Net Income | -283.01M |
| EBITDA | 67.51M |
| EBIT | -274.38M |
| Earnings Per Share (EPS) | -1.35 |
Full Income StatementBalance Sheet
The company has 191.66M in cash and 10.97M in
debt, giving a net cash position of 180.69M.
| Cash & Cash Equivalents | 191.66M |
| Total Debt | 10.97M |
| Net Cash | 180.69M |
| Retained Earnings | -164.86M |
| Total Assets | 690.57M |
| Working Capital | 272.09M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was 132.17M
and capital expenditures -10.61M, giving a free cash flow of 121.56M.
| Operating Cash Flow | 132.17M |
| Capital Expenditures | -10.61M |
| Free Cash Flow | 121.56M |
| FCF Per Share | 0.58 |
Full Cash Flow StatementMargins
Gross margin is 84.4%, with operating and profit margins of 14.18% and -70.54%.
| Gross Margin | 84.4% |
| Operating Margin | 14.18% |
| Pretax Margin | -68.79% |
| Profit Margin | -70.54% |
| EBITDA Margin | 16.83% |
| EBIT Margin | 14.18% |
| FCF Margin | 30.3% |
